Immunic Statistics

Total Valuation

Immunic has a market cap or net worth of $127.01 million. The enterprise value is $30.13 million.

Market Cap	127.01M
Enterprise Value	30.13M

Important Dates

The next estimated earnings date is Thursday, August 1, 2024, before market open.

Earnings Date	Aug 1, 2024
Ex-Dividend Date	n/a

Share Statistics

Immunic has 90.08 million shares outstanding. The number of shares has increased by 122.83% in one year.

Shares Outstanding	90.08M
Shares Change (YoY)	+122.83%
Shares Change (QoQ)	+118.17%
Owned by Insiders (%)	7.72%
Owned by Institutions (%)	64.28%
Float	52.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.52
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.09, with a Debt / Equity ratio of 0.01.

Current Ratio	5.09
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -170.20% and return on invested capital (ROIC) is -114.10%.

Return on Equity (ROE)	-170.20%
Return on Assets (ROA)	-124.70%
Return on Capital (ROIC)	-114.10%
Revenue Per Employee	n/a
Profits Per Employee	-$1.27M
Employee Count	77
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -46.79% in the last 52 weeks. The beta is 1.77, so Immunic's price volatility has been higher than the market average.

Beta (5Y)	1.77
52-Week Price Change	-46.79%
50-Day Moving Average	1.23
200-Day Moving Average	1.26
Relative Strength Index (RSI)	61.97
Average Volume (20 Days)	434,661

Short Selling Information

The latest short interest is 3.01 million, so 3.34% of the outstanding shares have been sold short.

Short Interest	3.01M
Short Previous Month	2.96M
Short % of Shares Out	3.34%
Short % of Float	5.76%
Short Ratio (days to cover)	12.77

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-95.85M
Pretax Income	-97.92M
Net Income	-97.92M
EBITDA	-97.82M
EBIT	-97.92M
Earnings Per Share (EPS)	-$1.83

Full Income Statement

Balance Sheet

The company has $97.31 million in cash and $433,000 in debt, giving a net cash position of $96.88 million or $1.08 per share.

Cash & Cash Equivalents	97.31M
Total Debt	433,000
Net Cash	96.88M
Net Cash Per Share	$1.08
Equity (Book Value)	83.58M
Book Value Per Share	0.93
Working Capital	82.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$75.28 million and capital expenditures -$261,000, giving a free cash flow of -$75.55 million.

Operating Cash Flow	-75.28M
Capital Expenditures	-261,000
Free Cash Flow	-75.55M
FCF Per Share	-$0.78

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Immunic does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-122.83%
Shareholder Yield	-122.83%
Earnings Yield	-77.10%
FCF Yield	-59.48%

Analyst Forecast

The average price target for Immunic is $15.00, which is 963.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$15.00
Price Target Difference	963.83%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 15, 2019. It was a reverse split with a ratio of 1:40.

Last Split Date	Apr 15, 2019
Split Type	Reverse
Split Ratio	1:40

Scores

Altman Z-Score	n/a
Piotroski F-Score	2